Financhill
Buy
60

KVUE Quote, Financials, Valuation and Earnings

Last price:
$17.00
Seasonality move :
-6.7%
Day range:
$16.75 - $17.05
52-week range:
$14.02 - $25.17
Dividend yield:
4.86%
P/E ratio:
22.81x
P/S ratio:
2.18x
P/B ratio:
3.06x
Volume:
41.6M
Avg. volume:
45.5M
1-year change:
-27.73%
Market cap:
$32.5B
Revenue:
$15.5B
EPS (TTM):
$0.74

Analysts' Opinion

  • Consensus Rating
    Kenvue, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 11 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $19.33, Kenvue, Inc. has an estimated upside of 13.93% from its current price of $16.97.
  • Price Target Downside
    According to analysts, the lowest downside price target is $17.00 representing 100% downside risk from its current price of $16.97.

Fair Value

  • According to the consensus of 13 analysts, Kenvue, Inc. has 13.93% upside to fair value with a price target of $19.33 per share.

KVUE vs. S&P 500

  • Over the past 5 trading days, Kenvue, Inc. has underperformed the S&P 500 by -0.36% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Kenvue, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Kenvue, Inc. revenues have been falling on a year-over-year basis for 6 quarters in a row. In the most recent quarter Kenvue, Inc. reported revenues of $3.8B.

Earnings Growth

  • Kenvue, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Kenvue, Inc. reported earnings per share of $0.21.
Enterprise value:
40.5B
EV / Invested capital:
2.05x
Price / LTM sales:
2.18x
EV / EBIT:
14.82x
EV / Revenue:
2.70x
PEG ratio (5yr expected):
0.67x
EV / Free cash flow:
24.79x
Price / Operating cash flow:
20.02x
Enterprise value / EBITDA:
12.27x
Gross Profit (TTM):
$8.7B
Return On Assets:
5.38%
Net Income Margin (TTM):
9.55%
Return On Equity:
13.85%
Return On Invested Capital:
7.47%
Operating Margin:
18.95%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $15.5B $15.5B $15B $3.9B $3.8B
Gross Profit $8.6B $8.9B $8.7B $2.3B $2.2B
Operating Income $3B $2.8B $2.7B $700M $713M
EBITDA $3.6B $3.4B $3.3B $882M $854M
Diluted EPS $0.92 $0.55 $0.74 $0.20 $0.21
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets -- $5.5B $5.9B $5.9B $6B
Total Assets -- $26B $27.1B $26.9B $27.2B
Current Liabilities -- $3.9B $5.2B $5.9B $6.2B
Total Liabilities -- $7.1B $16.2B $16.3B $16.6B
Total Equity -- $18.9B $10.9B $10.6B $10.6B
Total Debt -- -- $8.3B $7.1B $7.9B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $2.9B $1.9B $2.1B $249M $294M
Cash From Investing -$390M -$558M -$493M -$56M -$104M
Cash From Financing -$2.2B -$1.4B -$1.6B -$162M -$110M
Free Cash Flow $2.5B $1.4B $1.6B $190M $196M
KVUE
Sector
Market Cap
$32.5B
$131.7M
Price % of 52-Week High
67.42%
70.54%
Dividend Yield
4.86%
0%
Shareholder Yield
5.77%
2.32%
1-Year Price Total Return
-27.73%
-7.51%
Beta (5-Year)
--
0.259
Dividend yield:
4.86%
Annualized payout:
$0.81
Payout ratio:
100.24%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $17.01
200-day SMA
Sell
Level $20.57
Bollinger Bands (100)
Sell
Level 15.74 - 21.02
Chaikin Money Flow
Sell
Level -978.2M
20-day SMA
Buy
Level $16.69
Relative Strength Index (RSI14)
Buy
Level 56.69
ADX Line
Buy
Level 24.29
Williams %R
Neutral
Level -36.0248
50-day SMA
Buy
Level $16.05
MACD (12, 26)
Buy
Level 0.27
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Sell
Level -402.7M

Financial Scores

Hold
Altman Z-Score (Annual)
Level (2.5073)
Buy
CA Score (Annual)
Level (-0.2433)
Buy
Beneish M-Score (Annual)
Level (-2.6224)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (0.1667)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Stock Forecast FAQ

In the current month, KVUE has received 2 Buy ratings 11 Hold ratings, and 0 Sell ratings. The KVUE average analyst price target in the past 3 months is $19.33.

  • Where Will Kenvue, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Kenvue, Inc. share price will rise to $19.33 per share over the next 12 months.

  • What Do Analysts Say About Kenvue, Inc.?

    Analysts are divided on their view about Kenvue, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kenvue, Inc. is a Sell and believe this share price will drop from its current level to $17.00.

  • What Is Kenvue, Inc.'s Price Target?

    The price target for Kenvue, Inc. over the next 1-year time period is forecast to be $19.33 according to 13 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 11 analysts rate the stock a Hold.

  • Is KVUE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Kenvue, Inc. is a Hold. 11 of 13 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of KVUE?

    You can purchase shares of Kenvue, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kenvue, Inc. shares.

  • What Is The Kenvue, Inc. Share Price Today?

    Kenvue, Inc. was last trading at $17.00 per share. This represents the most recent stock quote for Kenvue, Inc.. Yesterday, Kenvue, Inc. closed at $16.97 per share.

  • How To Buy Kenvue, Inc. Stock Online?

    In order to purchase Kenvue, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
65
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock